Select a Region
North America

Read our latest news!

Posted on March 23, 20233/23/23

EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis   

Posted on March 21, 20233/21/23

APACMed Names EVERSANA® Knowledge Partner to Shape Digital Health Reimbursement Framework Across Region

Posted on February 23, 20232/23/23

Xspray Pharma Partners with EVERSANA® for the U.S. Launch and Commercialization of its Lead Product, Dasynoc (XS004) for the Treatment of Chronic Myeloid Leukemia (CML) and Acute Lymphatic Leukemia (ALL)

Posted on February 22, 20232/22/23

EVERSANA® CONSULTING Named a Top Ranked Consulting Firm by Vault Across Asia Pacific

Posted on February 21, 20232/21/23

Evoke Pharma and EVERSANA Selected to Present Results of Real-World Healthcare Utilization Analysis for Diabetic Gastroparesis Patients Treated with GIMOTI® Versus Oral Metoclopramide at the Digestive Disease Week Plenary Session

Posted on February 8, 20232/8/23

EVERSANA CONSULTING Named a Best Boutique Consulting Firm by Vault For the Second Consecutive Year

Posted on February 1, 20232/1/23

EVERSANA INTOUCH Wins Multiple 2023 PM360 Pharma Choice Awards

Posted on January 6, 20231/6/23

EVERSANA to Present at the 41st Annual J.P. Morgan Healthcare Conference

Posted on December 15, 202212/15/22

EVERSANA’s Direct-to-Patient Care Model Named One of The Most Innovative Strategies of 2022 by PM360

Posted on November 14, 202211/14/22

EVERSANA® Names Experienced Life Sciences Leader Sy Pretorius Chief Operating Officer & President, Outsourced Solutions to Propel Next-Generation Commercialization Services Worldwide